研究厄贝沙坦氢氯噻嗪片联合氨氯地平治疗原发性高血压病的疗效及安全性

To Study the Efficacy and Safety of Irbesartan Hydrochlorothiazide Tablets Combined with Amlodipine in the Treatment of Essential Hypertension

目的针对原发性高血压病人采取厄贝沙坦氢氯噻嗪片联合氨氯地平进行医治取得的疗效展开分析。方法参与本次研究的对象为2016年1月至2017年1月在我院进行医治的高血压病人30例,运用厄贝沙坦氢氯噻嗪片联合氨氯地平片进行医治,针对治疗效果进行观察。结果在本次治疗中,本组患者共计出现高心病1例、肾炎1例、脑中风1例、眼底出血1例。在整体治疗有效率上,囊括显效20例,有效10例,整体有效率为100.00%。结论在原发性高血压疾病的治疗中,运用厄贝沙坦氢氯噻嗪片联合氨氯地平片进行医治能够取得可观的效果,并减少并发症的发生,值得在临床上推荐广泛应用。

Objective To analyze the efficacy of Irbesartan and Hydrochlorothiazide Tablets combined with amlodipine in the treatment of essential hypertension. Methods The subjects involved in this study were 30 hypertensive patients treated in our hospital from January 2016 to January 2017, treated with Irbesartan and Hydrochlorothiazide Tablets combined with amlodipine, to observe the effect of the treatment. Results In this treatment, a total of 1 case of hypercardiac disease, 1 case of nephritis, 1 case of cerebral apoplexy, and 1 case of fundus hemorrhage occurred in this group of patients. In terms of overall treatment efficiency, 20 cases were markedly effective, 10 cases were effective, and the overall effective rate was 100.00%. Conclusion In the treatment of primary hypertensive disease, the use of irbesartan hydrochlorothiazide tablets combined with amlodipine tablets for treatment can achieve considerable results and reduce the occurrence of complications. It is worth recommending widely in clinical practice.